
|Articles|September 1, 2002
Call made for anti-inflammatory systemic Tx
Berlin - New therapeutic modalities are needed for treating thesubstantial population of acne patients with marked inflammatory diseaseand scarring. Available data indicate compounds with selective anti-inflammatoryactivity may help fill that niche, Christos C. Zouboulis, M.D., said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
A Patient–Physician Lens on the Real Burden of CHE
2
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
3
Celldex Advances Barzolvolimab into Phase 3 for Cold Urticaria and Symptomatic Dermographism
4
New Perspectives in Chronic Hand Eczema Care
5



















